Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research
Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]
Gracell Biotechnologies Appoints Dr. Yajin Ni as CTO
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]
Amgen Tezepelumab BLA Submitted to U.S. FDA
Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]
AbbVie’s RINVOQ® ▼ (upadacitinib) Accepted for Use
AbbVie (NYSE: ABBV) today announced that the Scottish Medicines Consortium (SMC) has issued a positive […]
3D Heart Scans to Give Faster Treatment
People in England with coronary heart disease will be seen, diagnosed and treated up to […]
Grand Rounds and Doctor On Demand to Merge, Creating First of its Kind Patient-Centric Integrated Virtual Healthcare Company
Grand Rounds, a leader in healthcare quality and navigation, and Doctor On Demand, the nation’s […]
Abingworth Raises $582 Million for New Clinical Co-development Fund – ACCD 2
Abingworth, a leading international life sciences investment group, today announced the final closing of its […]
Flagship Pioneering Unveils Laronde to Advance Endless RNA™
Flagship Pioneering today unveiled Laronde, a platform company developing Endless RNA™ (eRNA), a novel, engineered […]
FagronLab™ UV Air Steriliser Proves Successful Against COVID-19 Virus
A leading pharmaceutical company has launched a new UV air steriliser which has been tested […]
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more